Skip to main content
OpenTrials
Completed

NCT Number: NCT00403195

Clinical and Pathophysiological Description of Ocular Ischemic Syndrome

The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Ophthalmology, Glostrup Hospital, University of Copenhagen

Glostrup Municipality, 2600, Denmark

About this study

The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid arteries. In this study we will analyze why OIS is developed in some patients and not developed in others. The patients with OIS will be thorough examined and will be compared with 1) a control group of healthy people and 2) with control group of patients with diabetic retinopathy. Furthermore the impact of vascular surgery on OIS will be analyzed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ocular ischemic syndrome

Exclusion criteria

  • Any other active ocular disease

Sponsors and collaborators

Lead sponsor

Glostrup University Hospital, Copenhagen

Other

Collaborators

  • Rigshospitalet, Denmark
  • University Hospital, Gentofte, Copenhagen

Registry information

Official study title

Pathophysiological Analysis of Ocular Ischemic Syndrome and the Response to Vascular Surgery

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Nov 23, 2006
Registry last updated
Sep 10, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.